CIR.L Regulatory News (CIR)

CIR.L Information

There is currently no data for CIR

REMOVE ADS

Director Declaration

9 Sep 2015 17:55

RNS Number : 6064Y

Circassia Pharmaceuticals Plc

09 September 2015

For immediate release

Circassia Pharmaceuticals plc

Director Declaration

9 September 2015

In accordance with Listing Rule 9.6.14 (2), the Company announces that Paul R Edick, a Non-Executive Director of Circassia Pharmaceuticals plc (LSE: CIR), was appointed as a Non-Executive Director of PDL BioPharma Inc (NASDAQ: PDLI) on 8 September 2015. He was also appointed in June 2015 as a Non-Executive Director of Neos Therapeutics Inc, which closed its initial public offering (NASDAQ: NEOS) on 28 July 2015.

-Ends-

For further information, please contact:

Circassia Pharmaceuticals plc

Julien Cotta, Company Secretary

+44 (0) 1865 405560

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDNLLMFTMBAMBJA

Date		Source	Headline
8th Jul 2019	5:02 pm	RNS	Holding(s) in Company
5th Jul 2019	12:07 pm	RNS	Holding(s) in Company
2nd Jul 2019	5:56 pm	RNS	Holding(s) in Company
2nd Jul 2019	5:56 pm	RNS	Holding(s) in Company
2nd Jul 2019	5:55 pm	RNS	Holding(s) in Company
1st Jul 2019	4:55 pm	RNS	Holding(s) in Company
28th Jun 2019	7:00 am	RNS	Total Voting Rights
25th Jun 2019	4:57 pm	RNS	Block Listing Application
17th Jun 2019	4:35 pm	RNS	Price Monitoring Extension
7th Jun 2019	6:00 pm	RNS	Holding(s) in Company
7th Jun 2019	4:18 pm	RNS	Result of AGM
6th Jun 2019	6:23 pm	RNS	Holding(s) in Company
6th Jun 2019	4:11 pm	RNS	Holding(s) in Company
31st May 2019	7:00 am	RNS	Total Voting Rights
28th May 2019	5:58 pm	RNS	Holding(s) in Company
28th May 2019	5:56 pm	RNS	Holding(s) in Company
21st May 2019	9:05 am	RNS	Holding(s) in Company
14th May 2019	4:24 pm	RNS	Annual report and notice of AGM
8th May 2019	7:00 am	RNS	Publication of Tudorza Phase IV ASCENT in JAMA
3rd May 2019	2:18 pm	RNS	Issue of Equity
1st May 2019	7:00 am	RNS	Final Results
30th Apr 2019	7:00 am	RNS	Total Voting Rights
15th Apr 2019	11:55 am	RNS	Holding(s) in Company
1st Apr 2019	7:00 am	RNS	FDA approval of Duaklir for treatment of COPD
29th Mar 2019	4:40 pm	RNS	Second Price Monitoring Extn
29th Mar 2019	4:35 pm	RNS	Price Monitoring Extension
29th Mar 2019	3:58 pm	RNS	FDA website posts Duaklir NDA approval
29th Mar 2019	3:34 pm	RNS	Circassia announces FDA approval of Tudorza sNDA
29th Mar 2019	7:00 am	RNS	Total Voting Rights
5th Mar 2019	4:53 pm	RNS	Holding(s) in Company
4th Mar 2019	4:04 pm	RNS	Holding(s) in Company
28th Feb 2019	7:00 am	RNS	Total Voting Rights
11th Feb 2019	5:17 pm	RNS	Holding(s) in Company
8th Feb 2019	9:00 am	RNS	Notice of Results
6th Feb 2019	4:44 pm	RNS	Holding(s) in Company
6th Feb 2019	7:00 am	RNS	Holding(s) in Company
4th Feb 2019	5:57 pm	RNS	Holding(s) in Company
4th Feb 2019	8:06 am	RNS	Successful FDA Presubmission Meeting for AirNOvent
4th Feb 2019	8:06 am	RNS	Admission to AIM
1st Feb 2019	4:36 pm	RNS	Price Monitoring Extension
1st Feb 2019	4:03 pm	RNS	Holding(s) in Company
31st Jan 2019	7:00 am	RNS	Total Voting Rights
30th Jan 2019	5:30 pm	RNS	Circassia Pharmaceuticals
30th Jan 2019	4:41 pm	RNS	Second Price Monitoring Extn
30th Jan 2019	4:35 pm	RNS	Price Monitoring Extension
28th Jan 2019	3:30 pm	RNS	Holding(s) in Company
28th Jan 2019	3:30 pm	RNS	Holding(s) in Company
25th Jan 2019	11:49 am	RNS	Holding(s) in Company
24th Jan 2019	7:00 am	RNS	Commercial rights acquired from AIT Therapeutics
18th Jan 2019	2:22 pm	RNS	Block listing Interim Review

Latest Share Chat

CIR.L Regulatory News (CIR)

Director Declaration

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending